A shadow economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Investigational Treatment Gaining Traction Online
The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Followers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.
Active Commerce on Social Networks
Additionally, a flourishing market exists on messaging services, where groups with thousands of members share comparison images, injection guides and assertions of rapid UK delivery. Sellers market the drug there before redirecting customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Experts Express Concerns
Nevertheless, doctors and chemists have cautions that the sale of what remains an unapproved drug in the UK is a cause for concern and could result in individuals injecting products of uncertain source.
Several professionals stated the demand for retatrutide could be connected to the increasing price of approved weight loss products such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate pharmaceutical, marketing, and customer laws, risking fines, prosecution or imprisonment.
Platform Reaction and Content Removal
Based on TikTok, the platform has taken down problematic content and prohibited associated keywords and query recommendations. The company stated it was committed to maintaining the service secure and allocating resources in enhancing enforcement strategies.
Online Marketplace Activities
Research also discovered groups with up to 9,000 participants marketing retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with numerous of users, filled with photos of weight loss, positive testimonials and detailed instructions for preparing or administering at home.
Within minutes of joining one group, a seller shared WhatsApp details, where the majority of transactions take place. The vendor provided an guidebook and promised shipping within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, medical conditions or past usage.
Item Details and Pricing
Inside these groups, posts show black plastic parcels with postal service labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use pens typically priced at £160 for 20 milligrams. When questioned how much time a injector should be used, sellers give contradictory responses varying between a several days to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for the messaging service said it actively monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are injecting materials they can’t verify. Even if the science behind retatrutide is sound, these online products may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for authorized slimming medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.
Her staff has previously encountered individuals injured by personal administration from unverified sources. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”
Producer Position
A representative from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to potentially significant health risks”.
